CV5 Capital and Enzyme form a strategic partnership to launch institutional-grade tokenized fund solutions
Foresight News reported that CV5 Capital has announced a strategic partnership with global tokenized financial infrastructure provider Enzyme, which will serve as the foundational technology stack for its tokenized fund issuance and management. CV5 Capital plans to leverage Enzyme Onyx to build, launch, and manage a new generation of investment products, supporting investment strategies across a variety of asset classes including cryptocurrencies, securities, commodities, and US Treasuries.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Pendle Bridge integrates with BungeeExchange, supporting cross-chain transfers across 13 networks
Barclays significantly increased holdings in Tesla (TSLA.US) and Intel (INTC.US) in Q3, and bought Nasdaq ETF options for hedging
According to disclosures by the U.S. Securities and Exchange Commission (SEC), Barclays has submitted its third-quarter holdings report (13F) as of September 30, 2026.
SNT Holdings, Related Party Raise Combined Stake in SNTEnergy to 55.75% From 52.75%
Cold wave and rising fuel costs drive electricity prices in northeastern Japan and Tokyo to a four-year high
Japan's spot electricity prices surged to multi-year highs over the weekend.
Crypto prices
More
